IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Log in (now much improved!)

Citations for "Economic epidemiology and infectious diseases"

by Philipson, Tomas

For a complete description of this item, click here. For a RSS feed for citations of this item, click here.
as
in new window


  1. Brodeur, Abel & Lekfuangfu, Warn N. & Zylberberg, Yanos, 2017. "War, Migration and the Origins of the Thai Sex Industry," IZA Discussion Papers 10686, Institute for the Study of Labor (IZA).
  2. Rikard Forslid & Mathias Herzing, 2015. "On the Optimal Production Capacity for Influenza Vaccine," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, 06.
  3. Tomas J. Philipson & Anupam B. Jena, 2005. "Surplus Appropriation from R&D and Health Care Technology Assessment Procedures," Public Economics 0511021, EconWPA.
  4. Philipson Tomas J & Jena Anupam B, 2006. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," Forum for Health Economics & Policy, De Gruyter, vol. 9(2), pages 1-33, January.
  5. Brahmbhatt, Milan & Dutta, Arindam, 2008. "On SARS type economic effects during infectious disease outbreaks," Policy Research Working Paper Series 4466, The World Bank.
  6. Adeline Delavande & Dana Goldman & Neeraj Sood, 2007. "Criminal Prosecution and HIV-related Risky Behavior," NBER Working Papers 12903, National Bureau of Economic Research, Inc.
  7. Douglas Gollin & Christian Zimmermann, 2005. "Malaria," 2005 Meeting Papers 561, Society for Economic Dynamics.
  8. Mark Gersovitz & Jeffrey S. Hammer, 2004. "The Economical Control of Infectious Diseases," Economic Journal, Royal Economic Society, vol. 114(492), pages 1-27, 01.
  9. Darius Lakdawalla & Neeraj Sood & Dana Goldman, 2006. "HIV Breakthroughs and Risky Sexual Behavior," The Quarterly Journal of Economics, Oxford University Press, vol. 121(3), pages 1063-1102.
  10. Gersovitz, Mark & Hammer, Jeffrey S., 2005. "Tax/subsidy policies toward vector-borne infectious diseases," Journal of Public Economics, Elsevier, vol. 89(4), pages 647-674, April.
  11. Stefan Pichler & Nicolas Ziebarth, 2016. "The Pros and Cons of Sick Pay Schemes: Testing for Contagious Presenteeism and Shirking Behavior," NBER Chapters, in: Social Insurance Programs (Trans-Atlantic Public Economic Seminar - TAPES) National Bureau of Economic Research, Inc.
  12. Laxminarayan, Ramanan & Brown, Gardner M., 2001. "Economics of Antibiotic Resistance: A Theory of Optimal Use," Journal of Environmental Economics and Management, Elsevier, vol. 42(2), pages 183-206, September.
  13. Kuhn, Michael & Wrzaczek, Stefan & Prskawetz, Alexia & Feichtinger, Gustav, 2011. "Externalities in a life cycle model with endogenous survival," Journal of Mathematical Economics, Elsevier, vol. 47(4-5), pages 627-641.
  14. Goenka, Aditya & Liu, Lin & Nguyen, Manh-Hung, 2014. "Infectious diseases and economic growth," Journal of Mathematical Economics, Elsevier, vol. 50(C), pages 34-53.
  15. Douglas Gollin & Christian Zimmermann, 2007. "Malaria: Disease Impacts and Long-Run Income Differences," Working papers 2007-30, University of Connecticut, Department of Economics, revised Apr 2010.
  16. Matthew J. Neidell, 2008. "Information, Avoidance Behavior, and Health: The Effect of Ozone on Asthma Hospitalizations," NBER Working Papers 14209, National Bureau of Economic Research, Inc.
  17. Gardner Brown & Ramanan Laxminarayan, 1998. "Economics of Antibiotic Resistance," Discussion Papers in Economics at the University of Washington 0060, Department of Economics at the University of Washington.
  18. Tomas Philipson & Stephane Mechoulan, 2003. "Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets," NBER Working Papers 9598, National Bureau of Economic Research, Inc.
  19. Tomas Philipson & Stephane Mechoulan & Anupam Jena, 2006. "Health Care, Technological Change, and Altruistic Consumption Externalities," NBER Working Papers 11930, National Bureau of Economic Research, Inc.
  20. Javier Birchenall, 2007. "Escaping high mortality," Journal of Economic Growth, Springer, vol. 12(4), pages 351-387, December.
  21. Jens Ludwig & Dave E. Marcotte, 2005. "Anti-depressants, suicide, and drug regulation," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 24(2), pages 249-272.
  22. Ibuka, Yoko & Bessho, Shun-ichiro, 2015. "Subsidies for influenza vaccination, vaccination rates, and health outcomes among the elderly in Japan," Japan and the World Economy, Elsevier, vol. 36(C), pages 56-66.
  23. Djemaï, Elodie, 2008. "Is the risk taking of HIV-infection influenced by income uncertainty? : Empirical Evidence from Sub-Saharan Africa," MPRA Paper 11731, University Library of Munich, Germany.
  24. Hoy, Michael & Polborn, Mattias K., 2015. "The value of technology improvements in games with externalities: A fresh look at offsetting behavior," Journal of Public Economics, Elsevier, vol. 131(C), pages 12-20.
  25. Laxminarayan, Ramanan, 2001. "Bacterial Resistance and the Optimal Use of Antibiotics," Discussion Papers dp-01-23, Resources For the Future.
  26. Kessing, Sebastian G. & Nuscheler, Robert, 2006. "Monopoly pricing with negative network effects: The case of vaccines," European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
  27. Berthélemy, Jean-Claude & Gaudart, Jean & Thuilliez, Josselin, 2015. "Prevention or treatment? The case of malaria," Economics Letters, Elsevier, vol. 131(C), pages 16-19.
  28. Fenichel, Eli P., 2013. "Economic considerations for social distancing and behavioral based policies during an epidemic," Journal of Health Economics, Elsevier, vol. 32(2), pages 440-451.
  29. Barmby, Tim & Larguem, Makram, 2009. "Coughs and sneezes spread diseases: An empirical study of absenteeism and infectious illness," Journal of Health Economics, Elsevier, vol. 28(5), pages 1012-1017, September.
  30. Yarmand, Hamed & Ivy, Julie S. & Denton, Brian & Lloyd, Alun L., 2014. "Optimal two-phase vaccine allocation to geographically different regions under uncertainty," European Journal of Operational Research, Elsevier, vol. 233(1), pages 208-219.
  31. Pichler, Stefan & Ziebarth, Nicolas R., 2015. "The Pros and Cons of Sick Pay Schemes: A Method to Test for Contagious Presenteeism and Shirking Behavior," IZA Discussion Papers 8850, Institute for the Study of Labor (IZA).
  32. Skatun, John Douglas, 2003. "The overprovision of infectious disease medicine," Economics Letters, Elsevier, vol. 80(1), pages 61-66, July.
  33. Olson, Lars J., 2006. "The Economics of Terrestrial Invasive Species: A Review of the Literature," Agricultural and Resource Economics Review, Northeastern Agricultural and Resource Economics Association, vol. 35(1), April.
  34. Stefan Pichler & Nicolas R. Ziebarth, 2016. "The Pros and Cons of Sick Pay Schemes: Testing for Contagious Presenteeism and Noncontagious Absenteeism Behavior," NBER Working Papers 22530, National Bureau of Economic Research, Inc.
  35. Stéphane Mechoulan, 2007. "Market structure and communicable diseases," Canadian Journal of Economics, Canadian Economics Association, vol. 40(2), pages 468-492, May.
  36. Amarakoon Bandara, 2005. "Emerging health isues in Asia and the Pacific: implications for public health policy," Asia-Pacific Development Journal, United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), vol. 12(2), pages 33-58, December.
  37. Christopher S. Carpenter & Emily C. Lawler, 2017. "Direct and Spillover Effects of Middle School Vaccination Requirements," NBER Working Papers 23107, National Bureau of Economic Research, Inc.
  38. Howard Kunreuther & Geoffrey Heal, 2002. "Interdependent Security: The Case of Identical Agents," NBER Working Papers 8871, National Bureau of Economic Research, Inc.
  39. Wolf, Christopher A., 2005. "Producer Livestock Disease Management Incentives and Decisions," International Food and Agribusiness Management Review, International Food and Agribusiness Management Association (IFAMA), vol. 8(01).
  40. Momota, Akira & Tabata, Ken & Futagami, Koichi, 2005. "Infectious disease and preventive behavior in an overlapping generations model," Journal of Economic Dynamics and Control, Elsevier, vol. 29(10), pages 1673-1700, October.
  41. Auld, M. Christopher, 2003. "Choices, beliefs, and infectious disease dynamics," Journal of Health Economics, Elsevier, vol. 22(3), pages 361-377, May.
  42. Laxminarayan, Ramanan & Weitzman, Martin L., 2002. "On the implications of endogenous resistance to medications," Journal of Health Economics, Elsevier, vol. 21(4), pages 709-718, July.
  43. Gabriel Picone & Robyn Kibler & Bénédicte H. Apouey, 2013. "Malaria prevalence, indoor residual spraying, and insecticide-treated net usage in Sub-Saharan Africa," PSE Working Papers halshs-00911364, HAL.
  44. Stéphane Mechoulan, 2006. "Risky Sexual Behavior, Testing and New HIV Treatments," Working Papers tecipa-239, University of Toronto, Department of Economics.
This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.